1. Home
  2. WWW vs SDGR Comparison

WWW vs SDGR Comparison

Compare WWW & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolverine World Wide Inc.

WWW

Wolverine World Wide Inc.

HOLD

Current Price

$17.71

Market Cap

1.5B

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$13.15

Market Cap

856.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WWW
SDGR
Founded
1883
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
856.7M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
WWW
SDGR
Price
$17.71
$13.15
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$24.88
$24.33
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
2.25%
N/A
EPS Growth
96.55
45.14
EPS
1.14
N/A
Revenue
$1,874,300,000.00
$255,869,000.00
Revenue This Year
$5.37
$6.11
Revenue Next Year
$5.06
$7.69
P/E Ratio
$15.39
N/A
Revenue Growth
6.80
23.29
52 Week Low
$9.58
$11.11
52 Week High
$32.80
$27.63

Technical Indicators

Market Signals
Indicator
WWW
SDGR
Relative Strength Index (RSI) 46.66 50.36
Support Level $16.82 $11.11
Resistance Level $19.44 $19.51
Average True Range (ATR) 0.98 0.70
MACD -0.03 0.31
Stochastic Oscillator 17.52 92.22

Price Performance

Historical Comparison
WWW
SDGR

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: